The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ryan Charles S. since 2015.
This trader's CIK number is 1624830.
At the time of last reporting, Ryan Charles S. was the PRESIDENT of Quince Therapeutics, Inc.. (stock ticker symbol QNCX).
Also see all insider trading activities at Quince Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | BRTX | 206,250 | $75,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | QNCX | 48,387 | $31,451 | 0 | $0 | 0 | $0 |
1. Biorestorative Therapies, Inc. (BRTX)
2. Quince Therapeutics, Inc. (QNCX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-12-07 | BRTX | Buy | 6,250 | 4.00 | 25,000 |
| 2015-05-08 | BRTX | Buy | 200,000 | .25 | 50,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-20 | QNCX | Buy | 48,387 | .65 | 31,451 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ryan Charles S. (PRESIDENT of Quince Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.